ZIMMER BIOMET HOLDINGS, INC. (ZBH) is a publicly traded company in the Unknown sector. Across all available filings, 41 corporate insiders have executed 431 transactions totaling $2.2B, demonstrating a bearish sentiment with -$2.2B in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 21,701 shares valued at $0.
No significant insider buying has been recorded for ZBH in the recent period.
No significant insider selling has been recorded for ZBH in the recent period.
Based on recent SEC filings, insider sentiment for ZBH is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.2B. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ZIMMER BIOMET HOLDINGS, INC. (ZBH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 41 insiders are actively trading ZBH stock, having executed 431 transactions in the past 90 days. The most active insider is Group L.p. Blackstone (Executive), who has made 7 transactions totaling $705.1M.
Get notified when executives and directors at ZBH file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Upadhyay Suketu | Exec VP, CFO | Award | 21,701 | $N/A | $0 | C-Suite |
| Feb 20, 2026 | Upadhyay Suketu | Exec VP, CFO | Option Exercise | 5,445 | $N/A | $0 | C-Suite |
| Feb 20, 2026 | Upadhyay Suketu | Exec VP, CFO | Payment | 2,446 | $98.62 | $241.2K | C-Suite |
| Feb 20, 2026 | Upadhyay Suketu | Exec VP, CFO | Option Exercise | 5,445 | $N/A | $0 | C-Suite |
| Feb 20, 2026 | Tornos Ivan | Executive | Award | 65,103 | $N/A | $0 | |
| Feb 20, 2026 | Tornos Ivan | Executive | Option Exercise | 15,996 | $N/A | $0 | |
| Feb 20, 2026 | Tornos Ivan | Executive | Payment | 8,846 | $98.62 | $872.4K | Large |
| Feb 20, 2026 | Tornos Ivan | Executive | Option Exercise | 15,996 | $N/A | $0 | |
| Feb 20, 2026 | Winkler Lori | SVP and CHRO | Award | 7,880 | $N/A | $0 | |
| Feb 20, 2026 | Winkler Lori | SVP and CHRO | Option Exercise | 1,845 | $N/A | $0 | |
| Feb 20, 2026 | Winkler Lori | SVP and CHRO | Payment | 683 | $98.62 | $67.4K | |
| Feb 20, 2026 | Winkler Lori | SVP and CHRO | Option Exercise | 1,845 | $N/A | $0 | |
| Feb 20, 2026 | Wilfred Van Zuilen | Group Pres, EMEA | Award | 10,334 | $N/A | $0 | |
| Feb 20, 2026 | Wilfred Van Zuilen | Group Pres, EMEA | Option Exercise | 2,451 | $N/A | $0 | |
| Feb 20, 2026 | Wilfred Van Zuilen | Group Pres, EMEA | Payment | 638 | $98.62 | $62.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 127 | $2.2B | 97.2% |
Exercise(M) | 155 | $35.0M | 1.5% |
Payment(F) | 90 | $20.5M | 0.9% |
Purchase(P) | 34 | $7.4M | 0.3% |
Award(A) | 17 | $0 | 0.0% |
Gift(G) | 7 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at ZIMMER BIOMET HOLDINGS, INC. has increased, with 41 insiders executing 431 transactions across all time. Total sales of $2.2B significantly outpace purchases of $7.4M, resulting in a net outflow of $2.2B. This selling activity appears largely discretionary, which may warrant closer attention from investors.